Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) EBT Margin (2022 - 2023)

Historic EBT Margin for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to 28374.0%.

  • Lexeo Therapeutics' EBT Margin changed N/A to 28374.0% in Q4 2023 from the same period last year, while for Dec 2023 it was 32386.83%, marking a year-over-year change of. This contributed to the annual value of 71775.91% for FY2024, which is 393886000.0% up from last year.
  • As of Q4 2023, Lexeo Therapeutics' EBT Margin stood at 28374.0%.
  • In the past 5 years, Lexeo Therapeutics' EBT Margin ranged from a high of 38669.23% in Q3 2023 and a low of 3211.86% during Q3 2022